• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Cigna Group announces leadership changes to continue driving growth

    1/17/24 9:15:00 AM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email
    • Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna Healthcare
    • Ann Dennison to join The Cigna Group as Deputy Chief Financial Officer
    • Mike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna Healthcare
    • Eric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health Services

    BLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.

    The Cigna Group (PRNewsfoto/The Cigna Group)

    "Brian and Eric are experienced leaders whose depth of knowledge of both our enterprise and our industry will allow us to capitalize on the strengths of our foundational businesses while generating scale in our accelerated businesses," said David M. Cordani, chairman and chief executive officer, The Cigna Group. "With them at the helm of our two growth platforms, alongside their seasoned leadership teams, we believe we are well positioned to deliver on our strategy with clarity and purpose."

    Brian Evanko to continue as Chief Financial Officer for The Cigna Group, and assume expanded role as President and Chief Executive Officer, Cigna Healthcare

    Brian Evanko will continue to serve as Chief Financial Officer for The Cigna Group and assume the new role of President and Chief Executive Officer for Cigna Healthcare. He will oversee all Cigna Healthcare businesses, including U.S. Commercial, International Health, and U.S. Government. Evanko joined Cigna in 1998 and has held several business and financial leadership roles over the course of his tenure, including oversight of the U.S. Government business. During his time as CFO, the company has delivered against its earnings objectives.

    Ann Dennison joins The Cigna Group as Deputy Chief Financial Officer

    Ann Dennison will join The Cigna Group as Deputy Chief Financial Officer. Previously, she was an Executive Vice President and the Chief Financial Officer at Nasdaq, where she led a global team responsible for corporate finance, treasury, planning and analysis, investor relations, ESG reporting, procurement and real estate. Dennison joined Nasdaq in 2015 as Senior Vice President, Controller and Chief Accounting Officer, and prior to that, she was a Managing Director and Head of Financial Reporting at Goldman Sachs. Dennison holds a BBA/MBA in Accounting and Finance from Pace University's Lubin School of Business.

    Mike Triplett to retire by end of 2024; Bryan Holgerson named President, U.S. Commercial, Cigna Healthcare

    Current U.S. Commercial President Mike Triplett will retire by the end of 2024. During his tenure, he has overseen growth for the commercial business and drove Cigna Healthcare's work with network hospitals, facilities, and clinicians to improve affordability and enhance quality. As part of the transition plan, he will assume the role of special advisor to the CEO where he will focus on solutions for key distribution channels.

    Bryan Holgerson will be promoted to serve as President of U.S. Commercial for Cigna Healthcare. During his more than 22 years with the company, Holgerson has gained deep experience shaping and executing business growth strategies across a diverse portfolio. Prior to his current role leading U.S. Commercial National Accounts and the Underwriting team, Holgerson served as a Market President and held key leadership positions in National Accounts, among other senior roles.

    Dennison and Holgerson will report to Evanko.

    Eric Palmer to assume expanded role as Executive Vice President for Enterprise Strategy, The Cigna Group, and continue as President and Chief Executive Officer, Evernorth Health Services

    Eric Palmer will expand his role to assume oversight of The Cigna Group Enterprise Strategy and Corporate Development, in addition to continuing to serve as President and Chief Executive Officer, Evernorth Health Services. He will be responsible for mapping long-term growth strategies, further growing the enterprise's health services businesses through M&A activity and fueling innovation through Cigna Ventures. Over the course of his 26-year career with Cigna, Palmer has held many business and financial leadership positions, including serving as CFO from 2017 through 2020. Since assuming his current role leading Evernorth, the business has significantly grown while expanding its services offerings and innovating new capabilities. 

    About The Cigna Group:

    The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Evernorth Health Services, Cigna Healthcare, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has more than 165 million customer relationships around the world. Learn more at thecignagroup.com.

    Media Contact:

    Justine Sessions

    [email protected]

    Investor Relations Contact:

    Ralph Giacobbe

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-group-announces-leadership-changes-to-continue-driving-growth-302036419.html

    SOURCE The Cigna Group

    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    10/14/2025$370.00Buy
    Goldman
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    2/5/2024$334.00 → $372.00Neutral → Overweight
    Cantor Fitzgerald
    2/5/2024$327.00 → $354.00Sector Perform → Outperform
    RBC Capital Mkts
    2/1/2024$355.00 → $370.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Kates Jamie G was granted 814 shares and covered exercise/tax liability with 132 shares, increasing direct ownership by 40% to 2,368 units (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    3/3/26 7:20:05 PM ET
    $CI
    Medical Specialities
    Health Care

    Officer Neville Everett was granted 5,280 shares, covered exercise/tax liability with 1,400 shares and sold $496,636 worth of shares (1,719 units at $288.91), increasing direct ownership by 62% to 5,670 units (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    3/3/26 7:18:57 PM ET
    $CI
    Medical Specialities
    Health Care

    EVP, Global CIO Koka Durga Prasad was granted 3,177 shares and covered exercise/tax liability with 220 shares, increasing direct ownership by 68% to 7,281 units (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    3/3/26 7:19:26 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Cordani David bought $999,916 worth of shares (4,134 units at $241.88) (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    11/3/25 2:47:56 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Cigna Group

    SCHEDULE 13G/A - Cigna Group (0001739940) (Subject)

    3/5/26 1:24:31 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Cigna Group (0001739940) (Filer)

    3/3/26 7:42:12 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    3/2/26 1:30:26 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a+" (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI). The majority of Cigna's core U.S. health insurance entities are collectively referred to as Cigna Life & Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb+" (Good) and the Long-Term Issue Credit Ratings (Long-Term IR) of Cigna. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of Cigna. The outlook of these Credit Ratings (ratings) is stable. (

    3/4/26 5:40:00 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer

    Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of DirectorsEvanko elected to the company's Board of DirectorsCompany reaffirms 2026 Financial OutlookBLOOMFIELD, Conn., March 3, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO. Throughout his tenure—inclu

    3/3/26 7:30:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Announces Appearance at the TD Cowen 46th Annual Health Care Conference

    BLOOMFIELD, Conn., March 2, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Ann Dennison, Executive Vice President and CFO of The Cigna Group, and Adam Kautzner, President of Evernorth Care Management and Express Scripts, will present at the TD Cowen 46th Annual Health Care Conference today, March 2, 2026, in Boston, MA. The Cigna Group's presentation is expected to begin at approximately 1:50 p.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Invest

    3/2/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on The Cigna Group with a new price target

    Goldman initiated coverage of The Cigna Group with a rating of Buy and set a new price target of $370.00

    10/14/25 8:47:37 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group downgraded by Bernstein with a new price target

    Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

    2/6/25 7:05:01 AM ET
    $CI
    Medical Specialities
    Health Care

    Piper Sandler initiated coverage on The Cigna Group with a new price target

    Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00

    6/26/24 7:28:18 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Financials

    Live finance-specific insights

    View All

    AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a+" (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI). The majority of Cigna's core U.S. health insurance entities are collectively referred to as Cigna Life & Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb+" (Good) and the Long-Term Issue Credit Ratings (Long-Term IR) of Cigna. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of Cigna. The outlook of these Credit Ratings (ratings) is stable. (

    3/4/26 5:40:00 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend

    Total revenues for 2025 increased 11% to $274.9 billionShareholders' net income for 2025 was $6.0 billion, or $22.18 per shareAdjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2Board of Directors declared an increase in the quarterly dividend to $1.56 per shareBLOOMFIELD, Conn., Feb. 5, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported 2025 results, underscoring operational discipline and the strength of its complimentary portfolio of global health businesses.

    2/5/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group's Fourth Quarter 2025 Earnings Release Details

    BLOOMFIELD, Conn., Jan. 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2025 financial results on Thursday, February 5, 2026, and will host a conference call the same day. Fourth quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 02052026 Replay (866) 405-7290 (Domestic) (203) 369-0603 (

    1/13/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Leadership Updates

    Live Leadership Updates

    View All

    The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer

    Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of DirectorsEvanko elected to the company's Board of DirectorsCompany reaffirms 2026 Financial OutlookBLOOMFIELD, Conn., March 3, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO. Throughout his tenure—inclu

    3/3/26 7:30:00 AM ET
    $CI
    Medical Specialities
    Health Care

    VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTS

    Corporate, Nonprofit, and Philanthropic Partners Collaborated to Provide Transformative Experiences and Lasting Resources at Burckhalter Elementary School OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, a flagship initiative of Love Thy Neighbor CDC co-founded by NFL Executive and Legend Troy Vincent, Sr. and his wife, author and chef Tommi A. Vincent, took place Tuesday, February 3, at Burckhalter Elementary School in Oakland, CA. The ninth annual event, themed Dreams Grow Here, delivered a full day of fun, food, wellness, and engaging sports activities, including NFL FLAG, for more than 200 Pre-K through fifth-grade studen

    2/3/26 8:17:00 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors

    BLOOMFIELD, Conn., June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J. Hennigan has been appointed to the organization's Board of Directors. His appointment is effective June 2. Mr. Hennigan is the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC. He joined the company in 2017 and previously held the roles of Chief Executive Officer of MPC and Chairman, President and Chief Executive Officer of MPLX. Prior

    6/2/25 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/13/24 5:02:29 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/9/24 8:50:20 AM ET
    $CI
    Medical Specialities
    Health Care